Meda’s Sustainability Report presents how Meda works and performs within areas identified as particularly relevant in a sustainability and business context. Meda has reported in accordance with the Global Reporting Initiative (GRI) since 2010. The information is verified by third party (PwC) and for 2015 Meda reports in accordance with GRI G4, level core. The Sustainability Report is included in Meda’s Annual Report 2015, pages 41-63.
Meda’s value chain
Meda’s value chain comprises four basic stages;
The relevance, quality, price and availability of the products Meda provides are key attributes to Meda’s business and must be considered at every stage.
Meda works systematically with sustainability matters that are identified as relevant to the company’s business and in relation to prioritized stakeholders. Meda’s sustainability efforts shall be close to the business and support the overall objectives. The work on relevant sustainability matters is about, among other things, to identify risks and opportunities with an impact on the business and to build relationships with key stakeholders.
Meda’s sustainability agenda has four focus areas. They are;
Some highlights in 2015 were;
To set out a relevant sustainability agenda and to fulfill the G4 reporting requirements, Meda performed its second materiality assessment in 2015. This assessment confirmed previous focus areas. However, a slightly greater emphasis on sustainability management in the supply chain, employee development, and business ethics and anti-corruption was highlighted. This is thought to be due to greater general interest in sustainability, more clearly articulated customer expectations and stricter regulations, along with the 2014 acquisition of Rottapharm and Meda’s continued expansion in emerging markets.
More details are presented in the sustainability report 2015.